Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Journal of the Neurological Sciences|June 18, 2019
The impact of cervical spinal cord atrophy on quality of life in multiple sclerosisJonathan Zurawski, Bonnie I Glanz, Brian C Healy, et al.Multiple Sclerosis and Related Disorders|February 15, 2019
Time between expanded disability status scale (EDSS) scoresJonathan Zurawski, Bonnie I Glanz, Alicia Chua, et al.Multiple Sclerosis and Related Disorders|February 3, 2020
Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Cindy T Gonzalez, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 28, 2021
The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Emily C Casady, et al.Multiple Sclerosis and Related Disorders|June 16, 2022
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disordersSarah E Conway, Brian C Healy, Jonathan Zurawski, et al.International Forum of Allergy & Rhinology|February 17, 2012
Two-year results: transantral balloon dilation of the ethmoid infundibulumJames Stankiewicz, Theodore Truitt, James Atkins, et al.Seminars in Neurology|October 10, 2008
Neuroimaging of toxic and metabolic disordersAshish Arora, Mohit Neema, James Stankiewicz, et al.Multiple Sclerosis and Related Disorders|March 19, 2025
Immune response to influenza vaccine in patients with relapsing multiple sclerosis treated with ofatumumab: Results from an open-label, multicenter, phase 4 studyBrian Steingo, Adnan Subei, Emily Riser, et al.Scientific Reports|April 8, 2025
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosisAndrei Miclea, Jonathan Zurawski, Brian C Healy, et al.Multiple Sclerosis and Related Disorders|May 16, 2022
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case seriesGiovanna S Manzano, Kathryn B Holroyd, Tamara Kaplan, et al.Pageof 6